Multiple Sclerosis Patients Helped With Asthma Medication

Patients with multiple sclerosis could be helped by Albuterol, a drug used to treat asthma and other respiratory diseases, states a new research study.

Multiple sclerosis (MS) is a chronic inflammatory disease characterized by the degeneration of myelin, which coats nerve cells in the white matter of the central nervous system.

Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses

Patients with the condition have been found to have elevated levels of interleukin-12, a biological compound that promotes the generation of a type of helper T cell that may be associated with myelin destruction.

Albuterol sulfate-commonly used to treat bronchospasm, a constriction of the airways within the lungs as often occurs in asthma-may decrease interleukin-12 levels, the authors note.

Samia J. Khoury, of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues assessed the effects of albuterol treatment as an add-on therapy for patients starting treatment with glatiramer acetate, currently approved as a therapy for relapsing-remitting MS.

Asthma - Factors, Common Allergens, Diagnosis, Treatment, Support Groups, FAQs
It's a lung condition characterized by inflammation of the bronchi and constriction of the airways that result in coughing, wheezing or breathlessness. Allergy and other airway irritants can trigger it

A total of 44 patients were randomly assigned to receive daily subcutaneous (underneath the skin) 20-milligram injections of glatiramer acetate plus either an oral dose of 4 milligrams of albuterol or placebo daily for two years.

Participants were examined by a neurologist at the beginning of the study and at six, 12, 18 and 24 months, and blood samples were collected at the beginning and three, six and 12 months into the study.

Promising New Therapy for Relapsing Multiple Sclerosis
A new study has revealed that patients with relapsing multiple sclerosis who combine standard treatment with doses of a humanized monoclonal antibody called daclizumab might fewer relapses

Magnetic resonance imaging (MRI) of the brain was performed at enrollment, 12 months and 24 months.

A total of 39 patients participated long enough to contribute to the analysis.

Albuterol may Be Helpful for Infants Suffering from Bronchiolitis
Bronchiolitis, a wheezing much like asthma in adults, is responsible for many hospital admissions of infants.

In assessments of functional status, improvement was observed in the glatiramer acetate plus albuterol group compared with the placebo group at six months and 12 months but not at 24 months.

Compared to patients taking placebo, those taking albuterol also experienced a delay in the time to their first relapse.

"We conclude that treatment with glatiramer acetate plus albuterol is well tolerated and improves clinical outcomes in patients with multiple sclerosis. The combined regimen seems to enhance clinical response during the first year of therapy," the authors said.

The study appears in the September issue of Archives of Neurology, one of the JAMA/Archives journals.

Source-ANI